Short Report“So prohibition can work?” Changes in use of novel psychoactive substances among adolescents attending a drug and alcohol treatment service following a legislative ban
Section snippets
Background
Novel psychoactive substances (NPS) have become a source of international concern (European Commission, 2011). The marketplace for these drugs has also been novel. As most NPS were not scheduled in legislation as being illegal, they have been sold commercially both via the internet and in specialist shops known as ‘headshops’ (Dargan et al., 2011, Kelleher et al., 2011).
While NPS are very heterogeneous, they can be broadly grouped by route of use. Firstly, there are the powdered stimulant drugs
Setting
The Youth Drug & Alcohol (YoDA) service is a specialist drug and alcohol treatment service for adolescents in Dublin. Assessment involves clinical interview and completion of structured questionnaires. Building of a therapeutic alliance is prioritised over data gathering. There were no changes to service delivery or referral criteria over the period 2009–2011.
Measures
The National Drug Treatment Report System (NDTRS) form is completed on all patients who complete assessment. Between one and four current
Results
There were 94 assessments commenced by 92 adolescents, with 50 during the pre-ban period, and 44 during the post-ban period. The median age was 17 years (interquartile range [IQR] 15–17) and 83% were male. Only 69% were engaged in education, training or employment. The main referrers were parents (45%) and social workers (21%). There were significantly more males in the pre-ban period (92% vs 73%, p = 0.01). There were no other significant differences between the groups with regard to
Discussion
We found substantial reductions in use of NPS among adolescents entering treatment 6–12 months after legislation prohibiting their use, supply and sale. We deliberately cast the net wide in terms of NPS due to concerns that success at reducing use of a single drug-type might conceal increased use of other emerging and not yet illegal NPS (Dargan et al., 2011). Further new substances did indeed arrive into the drugs marketplace in Ireland following the initial legislation (Kavanagh and Power,
Funding
No external funding was obtained for the purposes of this research project.
Conflict of interest
None of the authors have any conflicts of interest to declare.
References (15)
The term and the vision
International Journal of Drugs Policy
(2012)- et al.
The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in ‘Spice’
International Journal of Drugs Policy
(2011) - et al.
If supply-orientated policy is broken, can harm reduction help fix it? Melding disciplines and methods to advance international drugs policy
International Journal of Drugs Policy
(2012) - et al.
Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply
International Journal of Drugs Policy
(2011) - et al.
The impact of the prohibition of benzylpiperazine (BZP) ‘legal highs’ on the prevalence of BZP, new legal highs and other drug use in New Zealand
Drug and Alcohol Dependence
(2013) - et al.
Mephedrone: Still available and twice the price
Lancet
(2010) - et al.
Alcohol: No ordinary commodity. Research and public policy
(2010)